Similarly, JWH133 treatment resulted in reduced IL-1β release from mouse primary AMs in response to PA infection as observed by lower IL-1β levels in the supernatant of AMs treated with JWH133 as compared to that of vehicle-treated AMs. This evidence concerns the gene IL1B and infection.